Mannin Research
2012
FOUNDED
M&A
STATUS
1-10
EMPLOYEES
Grant
LATEST DEAL TYPE
$5.7M
LATEST DEAL AMOUNT
2
INVESTORS
Description
Developer of a medical technology intended to help treat glaucoma and cystic kidney diseases. The company's therapeutics use the Tie2 mechanism to address a number of vascular disease indications to treat vascular-related diseases, such as Primary Open Angle Glaucoma, Pediatric Glaucoma, Cystic Kidney Disease and Inflammation, enabling medical professionals to treat patients with a spectrum of vascular diseases.
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
Q BioMed
Primary Office
- 629 Eastern Avenue
- Suite C300
- Toronto, Ontario M4M 1E4
- Canada
+1 (416) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Mannin Research’s full profile, request a free trial.
Mannin Research Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 05-Nov-2019 | $5.7M | Completed | Pre-Clinical Trials | ||
| 3. Accelerator/Incubator | 02-Feb-2017 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 1. Merger/Acquisition | 13-Jan-2016 | Completed | Pre-Clinical Trials |
Mannin Research Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Matter | Accelerator/Incubator | 000 0000 | 000000 0 |
Mannin Research Executive Team (4)
Mannin Research Board Members (3)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Christopher Smith | Self | Chairman | 000 0000 | |
| Geoffrey Smith | Mannin Research | Secretary of the Board of Directors | 000 0000 | |
| Susan Quaggin | Mannin Research | Chief Scientific Officer & Board Member | 000 0000 |